Long-term treatment of obese, insulin-resistant nonhuman primates with a seed-targeting antimiR oligonucleotide against the microRNA-33 family derepresses hepatic expression of miR-33 targets, increases circulating HDL cholesterol, and has a clean safety profile.
A new high-throughput measurement technique by Tse et al. (this issue) moves mechanical phenotyping of cells in malignant pleural effusions closer to the clinic.
Translational Research Solutions Sigma-Aldrich has built a comprehensive approach to strengthen and support academic Translational Research. Incorporating our history of serving the pharmaceutical industry and our deep expertise in chemistry and biology basic research, Sigma-Aldrich provides both the fundamental and novel technologies that ensure greater accuracy, reproducibility and confidence in drug discovery research. Our continuing investment in innovation and quality supports the mission of Translational Research and, through your success, enables science to improve the quality of human life.